Invasive Pneumococcal Disease Surveillance, 1 January to 31 March 2017.

Invasive Pneumococcal Disease Surveillance, 1 January to 31 March 2017. Commun Dis Intell Q Rep. 2017 Dec 01;41(4):E472-E480 Authors: Pennington K, Enhanced Invasive Pneumococcal Disease Surveillance Working Group, for the Communicable Diseases Network Australia Abstract The number of notified cases of invasive pneumococcal disease (IPD) in the first quarter of 2017 was less than the previous quarter, but greater than the number of notified cases in the first quarter of 2016. Overall, the decline in disease due to the serotypes targeted by the 13-valent pneumococcal conjugate vaccine (13vPCV) has been maintained across all age groups since the 13vPCV replaced the 7-valent pneumococcal conjugate vaccine (7vPCV) in the childhood immunisation program from July 2011 (Figure 1). PMID: 29864392 [PubMed - in process]
Source: Communicable Diseases Intelligence Quarterly Report - Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research